Checking endothelial cell health before corneal transplant
Part of Eyes & vision clinical trials.
This study tests how well a patient’s corneal lining cells are preserved before corneal transplantation, and uses that to guide the transplant approach. It may help improve transplant planning and outcomes for people who need treatment for conditions like keratoconus or Fuchs endothelial dystrophy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- You are planning a corneal transplant that replaces the cornea’s inner lining cells (PK, DSAEK, UT-DSAEK, or DMEK)
- Your reason for transplant is keratoconus or Fuchs endothelial dystrophy (lower-to-moderate rejection risk)
- You have not had a corneal transplant before
- You do NOT have a current corneal infection (microbial keratitis) or non-infectious/autoimmune keratitis
- You do not have eye conditions that would block the study, like a corneal perforation, active/inflamed uveitis, uncontrolled high eye pressure, planned preloaded DSAEK/DMEK, or an anterior chamber lens
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new approach to help prevent cornea transplant failure in people with high-risk conditions, such as blood vessels growing into the cornea. It aims to see if this treatment can improve transplant success.
This trial tests a new treatment, EO2002, for people with corneal swelling that causes vision loss. It aims to offer an alternative to corneal transplant for those with conditions like Fuchs dystrophy or swelling after cataract surgery.
This study looks at a specific type of cornea transplant (called endothelial lamellar transplant) for people with Fuchs disease or other causes of corneal swelling that affect vision. It aims to see whether this surgical approach improves outcomes and quality of life after surgery.
This trial looks at how to manage medicine around DMEK corneal transplant surgery to improve eye outcomes and safety. It may help people having this specific type of cornea transplant by testing an approach in the time after surgery.
This trial tests a special intraocular lens that works with a cornea transplant procedure (DMEK) for people who have both cataracts and Fuchs' endothelial corneal dystrophy. It aims to see if this lens improves vision and reduces the need for glasses.
This trial tests a type of corneal transplant (DMEK) in people who have had previous eye surgeries, such as vitrectomy or glaucoma surgery. It aims to see if the transplant works well even in these complicated cases.
Hear when a new Corneal Transplant Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.